Back to Journals » Journal of Asthma and Allergy » Volume 11

Underuse of epinephrine for the treatment of anaphylaxis: missed opportunities

Authors Prince BT, Mikhail I, Stukus DR

Received 9 December 2017

Accepted for publication 9 January 2018

Published 20 June 2018 Volume 2018:11 Pages 143—151

DOI https://doi.org/10.2147/JAA.S159400

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Colin Mak

Peer reviewer comments 2

Editor who approved publication: Dr Luis Garcia-Marcos


Benjamin T Prince, Irene Mikhail, David R Stukus

Division of Allergy and Immunology, Nationwide Children’s Hospital, The Ohio State University College of Medicine, Columbus, OH, USA

Abstract: Epinephrine is the only effective treatment for anaphylaxis but studies routinely show underutilization. This is especially troubling given the fact that fatal anaphylaxis has been associated with delayed administration of epinephrine. Many potential barriers exist to the proper use of epinephrine during an anaphylactic reaction. This article will explore both patient- and physician-related factors, as well as misconceptions that all contribute to the underuse of epinephrine for the treatment of anaphylaxis.

Keywords: anaphylaxis, epinephrine, emergency department, food allergy
 

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]